Because opioid and cannabinoid systems have been reported to interact in the modulation of addictive behaviour, this study was aimed at investigating the ability of cannabinoid agents to reinstate or prevent heroin‐seeking behaviour after a prolonged period of extinction. In rats previously trained to self‐administer heroin intravenously, non‐contingent non‐reinforced priming administrations of heroin and cannabinoids were presented after long‐term extinction, and lever pressing following injections was observed. Results showed that: (i) intravenous priming infusions of heroin (0.1 and 0.2 mg/kg) lead to reinstatement of drug‐seeking behaviour; (ii) intraperitoneal priming injections of the central cannabinoid receptor agonists R‐(+)‐(2,3‐dihydro‐5‐methyl‐3‐((4‐morpholinyl)methyl)pyrol(1,2,3‐de)‐1,4‐benzoxazinyl) (1‐naphthalenyl)methanonemesylate (WIN 55,212‐2, 0.15 and 0.3 mg/kg) and (–)‐cis‐3‐(2‐hydroxy‐4(1,1‐dimethyl‐heptyl)phenyl)‐trans‐4‐(3‐hydroxypropyl) cyclohexanol (CP 55,940, 0.05 and 0.1 mg/kg), but not Δ9‐tetrahydrocannabinol (Δ9‐THC, 0.1–1.0 mg/kg), effectively restored heroin‐seeking behaviour; (iii) intraperitoneal priming injection of the central cannabinoid receptor antagonist N‐(piperidin‐1‐yl)‐5‐(4‐chlorophenyl)‐1‐(2,4‐dichloro‐phenyl)4‐methyl‐1H‐pyrazole‐3‐carboxamide (SR 141716A, 0.3 mg/kg) did not reinstate responding, but (iv) completely prevented heroin‐induced reinstatement of drug‐seeking behaviour. Moreover, heroin‐seeking behaviour was still present for a few days following cannabinoid primings, indicating a long‐lasting effect of cannabinoids on responding for heroin. These findings indicate that relapse to heroin after an extended drug‐free period is triggered by cannabinoid agonists and that SR 141716A prevents drug‐seeking behaviour, suggesting that the use of the cannabinoid antagonist could have some therapeutic benefits in heroin‐induced relapse.
European Journal of Neuroscience – Wiley
Published: Apr 1, 2003
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera